CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Amgen (AMGN) Stock Could Be 40% Undervalued On KRAS Market Growth News

Positive
AI Analysis

Summary

An analyst suggests Amgen stock could be undervalued by 40% based on KRAS market growth potential. The article discusses valuation implications related to Amgen's KRAS program.

Importance:3/10
Sentiment:
0.60
KRASvaluationmarket_opportunity
Related Companies

Read the original article

Published by yahoo_finance on October 9, 2026 9:17 PM

Read Original